Rory Shallis

54PUBLICATIONS
101CO-AUTHORS
Cardiovascular medicine and haematology not elsewhere classifiedHaematological tumoursMedical molecular engineering of nucleic acids and proteinsIntensive careGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (54)

|Jun 22, 2026
Limited Survival Benefit and High Healthcare Utilization With AML-Directed Therapy in Older Patients With TP53-Mutated Acute Myeloid Leukemia.

|Apr 09, 2026
Predictors of complete molecular response and impact of allogeneic hematopoietic stem cell transplantation on outcome in patients with Philadelphia chromosome positive acute lymphoblastic leukemia (ALL): results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Razan Mohty, Ravi Narra, Alice S Mims

|Feb 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating Agents.

Dimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni

|Oct 29, 2025
Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.

Cameron J Hunter, Wei Cheng, Jan Philipp Bewersdorf

|Jun 23, 2025
Integrated Immune Landscape Analysis of RNA Splicing Factor-Mutant AML and Higher risk MDS Treated with Azacitidine ± Durvalumab.

Jan Philipp Bewersdorf, Vanessa Hasle, Rory M Shallis

|May 22, 2025
Heterogeneity in outcomes of TP53-mutated myeloproliferative neoplasms based on disease phenotype and mutational status.

Talha Badar, James M Foran, Jan Philipp Bewersdorf

Pageof 9

Frequent Collaborators

24 joint publications

Jan Philipp Bewersdorf

10 joint publications

Nikolai A Podoltsev

6 joint publications

Anand Patel

6 joint publications

Scott F Huntington